Previous close | 882.60 |
Open | 890.40 |
Bid | 883.20 x 0 |
Ask | 883.20 x 0 |
Day's range | 881.60 - 894.60 |
52-week range | 504.40 - 932.00 |
Volume | |
Avg. volume | 2,643,997 |
Market cap | 3.935T |
Beta (5Y monthly) | 0.19 |
PE ratio (TTM) | 44.45 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 12.80 (1.45%) |
Ex-dividend date | 22 Mar 2024 |
1y target est | N/A |
The company will collaborate with a biotech founded by Flagship Pioneering, the venture capital firm that created Moderna.
According to the average brokerage recommendation (ABR), one should invest in Novo Nordisk (NVO). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
In this article, we discuss the 13 best stocks that will always grow. To skip the detailed analysis of the current economic landscape, go directly to the 5 Best Stocks That Will Always Grow. At the Federal Reserve’s May 1 meeting, Chairman Jerome Powell focused on the Fed’s dual mandate of promoting maximum employment and […]